In conclusion, our study provides a new perspective for exploring the mechanism of RGS family genes in the development of gastric cancer and proposes possible therapy through drug sensitivity studies, which is critical for precision medicine in gastric cancer. The gene discussed is PITX2; the disease is gastric cancer.